Global Gamma Probe Device Market Analysis
Using a gamma probe instrument, surgeons may detect radio-labeled tissue before and during surgery for radio-guided diagnosis and surgery. Tissues such as lymph nodes, tumors, and parathyroid glands are notoriously difficult for surgeons to detect within the human body. The use of a gamma probe allows the surgeon to create a smaller incision while preserving the tissues of interest. One of the most popular use of gamma probes is in a surgical technique called Sentinel Node Biopsy, which is used to see if a tumor has migrated to new places. Biopsies are commonly used to stage breast cancer and melanoma, and are becoming more prominent in the screening of other cancers.
Product introductions with enhanced features, increased awareness among the public about the benefits of gamma radiation over other detection techniques such as X-ray, and increasing acceptance rate among patients and its use by surgeons are driving the global gamma probe device market.
Over the forecast period, new product releases by major players will drive the global gamma probe device market forward. Dilon Technologies, Inc., a leading developer of innovative medical solutions, released the purple Navigator 2.0 gamma probe system for sentinel lymph node biopsy in July 2016. In 2016, EPFL researchers created a wireless gamma probe that can be carried in the hand and is low in weight, with the goal of detecting cancer cells and questionable lymph nodes during surgery. According to the IAEA (International Atomic Energy Agency), parathyroid detection is becoming more common, but intraoperative use of gamma probes for direct tumor detection is still in its early stages.
Ask for PDF sample copy of the Gamma Probe Device market report @ https://www.coherentmarketinsights.com/insight/request-pdf/1590
Furthermore, the global gamma probe device market is projected to expand due to the rising prevalence and high incidence of cancer. Breast cancer is the most prevalent disease in women globally and the second most common cancer overall, according to the World Cancer Research Fund International, with about 1,671,000 new reported incidents in 2012. The frequency of invasive thyroid cancer was 13.5 per 100,000 in 2009, according to the Centers for Disease Control and Prevention, and climbed to 14.5 per 100,000 in 2014. Furthermore, the Breast Cancer Organization estimates that 266,120 new instances of invasive breast cancer will be identified in the U.S. in 2018. Breast cancer incidence rates in the U.K. are projected to be the sixth highest in Europe, according to Cancer Research U.K. Furthermore, the number of people surviving beyond a cancer diagnosis reached almost 14.5 million in 2014, according to the National Institute of Health, and is anticipated to reach nearly 19 million by 2024. The global gamma probe market will be further swelled as a result of the large number of undiagnosed patients.
The global gamma probe device market will grow as the frequency of cancer operations rises. According to a 2015 report published in The Lancet Oncology, nearly 80% of the 15•2 million new cases of cancer diagnosed in 2015 will require surgery. According to the report, the global yearly number of surgical procedures would reach 45 million by 2030.
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/1590
Reasons to Purchase this Report
• Current and future of global Gamma Probe Device market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
“Limited Time Offer”
Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/1590
However, patients’ choice of a cost-effective option is projected to be a key roadblock for the global gamma probe device market.
Major companies contributing in the global gamma probe device market include Wake Medical Ltd., Lake Shore Cryotronics, Inc., Dilon Technologies, Inc., Berkeley Nucleonics Corporation, Intramedical Imaging, and Ziteo Inc.
The global gamma probe device market will grow in the near future as a result of market players’ initiatives to increase their product offering. Dilon Technologies, Inc. purchased the Navigator gamma probe business of RMD Instruments Corp., a Dynastic Corporation of America subsidiary, in 2014.
To get detailed table of content (ToC), please click –https://www.coherentmarketinsights.com/ongoing-insight/toc/1590
Table of Content
Global Gamma Probe Device Market Research Report
Section 1: Global Gamma Probe Device Industry Overview
Section 2: Global Economic Impact on Gamma Probe Device Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Gamma Probe Device Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Gamma Probe Device Market Forecast
Other Exclusive Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027